Myriad Genetics Inc (MYGN)
Fixed asset turnover
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 794,900 | 766,400 | 745,400 | 731,500 | 696,200 | 691,900 | 675,200 | 820,600 | 831,200 | 839,900 | 846,300 | 666,200 | 590,100 | 564,400 | 586,600 | 627,900 | 750,000 | 801,700 | 822,500 | 840,100 |
Property, plant and equipment | US$ in thousands | 116,300 | 118,500 | 119,000 | 120,700 | 112,000 | 96,300 | 83,400 | 67,500 | 52,800 | 45,700 | 43,500 | 43,400 | 43,200 | 45,100 | 36,700 | 37,000 | 37,100 | 36,500 | 55,000 | 57,300 |
Fixed asset turnover | 6.83 | 6.47 | 6.26 | 6.06 | 6.22 | 7.18 | 8.10 | 12.16 | 15.74 | 18.38 | 19.46 | 15.35 | 13.66 | 12.51 | 15.98 | 16.97 | 20.22 | 21.96 | 14.95 | 14.66 |
June 30, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $794,900K ÷ $116,300K
= 6.83
Myriad Genetics Inc's fixed asset turnover has fluctuated over the past several quarters, ranging from a low of 6.06 to a high of 21.96. A high fixed asset turnover ratio indicates that the company is generating significant revenue relative to its investment in fixed assets. This suggests efficient utilization of fixed assets in generating sales.
The downward trend in fixed asset turnover from 2022 to 2024 could be an indication of slower sales growth relative to the investment in fixed assets during this period. However, it is important to note that the fixed asset turnover ratio is still relatively high compared to previous years, indicating that Myriad Genetics Inc continues to efficiently use its fixed assets to generate revenue.
An area of concern could be the significant increase in fixed asset turnover from the end of 2021 to the beginning of 2022, followed by a gradual decline. This rapid increase may warrant further investigation to determine the reason behind such fluctuations in the efficiency of asset utilization.
Overall, the trend in Myriad Genetics Inc's fixed asset turnover suggests that the company has been effectively managing its fixed assets to generate revenue, although there have been fluctuations in efficiency over the past few quarters that may require closer attention.
Peer comparison
Jun 30, 2024